Skip to main content

Xtoro FDA Approval History

FDA Approved: Yes (Discontinued) (First approved December 17, 2014)
Brand name: Xtoro
Generic name: finafloxacin
Dosage form: Otic Suspension
Company: Alcon Laboratories, Inc.
Treatment for: Otitis Externa

Marketing Status: Discontinued

Xtoro (finafloxacin otic suspension) is a fluoroquinolone antimicrobial for the treatment of acute otitis externa, commonly known as swimmer’s ear.

Development timeline for Xtoro

Dec 17, 2014Approval FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.